Quick Answer
Zymeworks Inc. reported Stockholders Equity of $268.50 million for fiscal year 2025.
Zymeworks Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $268.50M | -20.7% |
| 2024 | $338.77M | -27.1% |
| 2023 | $464.81M | -5.7% |
| 2022 | $492.96M | +97.9% |
| 2021 | $249.09M | -39.2% |
| 2020 | $409.92M | +66.9% |
| 2019 | $245.68M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $320.06M | -12.8% | -4.3% |
| June 30, 2025 | $334.51M | -17.6% | +2.9% |
| March 31, 2025 | $324.97M | -25.8% | -4.1% |
| December 31, 2024 | $338.77M | -27.1% | -7.7% |
| September 30, 2024 | $366.98M | -13.5% | -9.6% |
| June 30, 2024 | $406.16M | -9.5% | -7.3% |
| March 31, 2024 | $438.00M | -7.5% | -5.8% |
| December 31, 2023 | $464.81M | -5.7% | +9.5% |
- Zymeworks Inc. showed a decrease of -20.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Zymeworks Inc.’s stockholders equity has grown by 9.3% (from $245.68 million to $268.50 million).
- The most recent figure is from Zymeworks Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: